摘要 |
The invention discloses a proteinic product extracted from non-pathogene bacillus and comprising proteins, peptides and other molecules obtained from the cellular lysis over at least one or the two sporulated and thermal resistant bacillus strains, in natural or modified form, and selected among a first group comprised of strains of <u>B. Licheniformis</u>, <u>B. Circulans 2</u>, <u>B. Pumilus</u>, <u>B. Macerans</u>, <u>B. Amilolicuofaciens</u>; a second group comprised of strains of <u>B. Cereus 1</u>, <u>B. Cereus 2</u>, <u>B. Lentus 1</u>, <u>B. Lentus 2</u>; a third group comprised of strains of <u>B. Subtilis</u>; a fourth group comprised of strains of <u>B. Mesentericus</u>. The invention also relates to a process for the preparation of the proteinic product, compositions which contain it and its use in the preparation of medicaments for the treatment of diseases related to syndromes of immunodeficiency, self-immunity, neoplasic processes, degenerative diseases, inflammatory intestinal diseases and infectious diseases. |